Home
Point72 Asset Management reported a 2.6% stake in Celldex Therapeutics CLDX · 1,758,357 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 2.6%
- Last report
- 6.7% · filed 25/07/10
- Shares held
- 1,758,357 sh
- Class
- Common Stock, par value $0.001 per share
- Holder
- Point72 Asset Management
- Event date
- 25/12/31
- Filed
- 26/03/10
2.6% stake · below 5%
- Stake
- 2.6%
- Last report
- 6.7%
- Since last report
- −4.1pp
Celldex Therapeutics trades, last 26 weeks
What else happened in Celldex Therapeutics around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30Point72 Asset Management's other 5% stake reports
- Point72 Asset Management
5% stakeViridian Therapeutics, Inc.\DE
5% stakeViridian Therapeutics, Inc.\DE
VRDN
5% stake
5,687,507 sh
5% stake
Filed 08/20
- Point72 Asset Management
5% stakeRxSight
5% stakeRxSight
RXST
6% stake
2,487,468 sh
6% stake
Filed 08/19
- Point72 Asset Management
5% stakeNeuronetics
5% stakeNeuronetics
STIM
5% stake
3,822,124 sh
5% stake
Filed 08/14
- Point72 Asset Management
5% stakeZepp Health
5% stakeZepp Health
ZEPP
0% stake
0 sh
0% stake
Filed 08/14
- Point72 Asset Management
5% stakeVnet Group
5% stakeVnet Group
VNET
6.6% stake
109,989,366 sh
6.6% stake
Filed 08/14
